Center for Health Promotion and Disease Prevention, Edson College of Nursing and Health Innovation, Arizona State University, 500 N 3rd St., Phoenix, AZ 85004, USA.
College of Nursing and Health Innovation, Arizona State University, 500 N 3rd St., Phoenix, AZ 85004, USA.
Int J Environ Res Public Health. 2023 Jan 5;20(2):1000. doi: 10.3390/ijerph20021000.
This article reports the results of Smart Walk: a randomized pilot trial of an 8-month culturally tailored, smartphone-delivered physical activity (PA) intervention for African American women with obesity. Sixty participants (age range = 24−49 years; BMI range = 30−58 kg/m2) were randomized to the Smart Walk intervention (n = 30) or a wellness comparison intervention (n = 30). Results supported the acceptability and feasibility of the intervention, as demonstrated by participant retention (85% at 4 months and 78% at 8 months), Smart Walk app use, and intervention satisfaction (i.e., 100% of PA participants completing the intervention [n = 24] reported they would recommend it to friend). Smart Walk participants also reported greater increases in moderate-to-vigorous PA (4-month between-arm difference in change [b] = 43.3 min/week; p = 0.018; Cohen’s d = 0.69; 8-month b = 56.6 min/week; p = 0.046; d = 0.63) and demonstrated clinically relevant, although not statistically significant (p-values > 0.05), baseline to 4 months improvements in cardiorespiratory fitness (b = 1.67 mL/kg/min; d = 0.40), systolic blood pressure (b = −3.33 mmHg; d = 0.22), diastolic blood pressure (b = −4.28 mmHg; d = 0.37), and pulse wave velocity (b = −0.46 m/s; d = 0.33). Eight-month cardiometabolic outcomes followed similar trends, but had high rates of missing data (45−53%) due to COVID-19 restrictions. Collectively, findings demonstrated favorable outcomes for acceptability and feasibility, while also highlighting key areas for refinement in future research.
本文报道了 Smart Walk 的研究结果:一项为期 8 个月的文化适应、智能手机提供的体育活动(PA)干预的随机试点试验,针对的是肥胖的非裔美国女性。60 名参与者(年龄范围为 24-49 岁;BMI 范围为 30-58kg/m2)被随机分配到 Smart Walk 干预组(n=30)或健康比较干预组(n=30)。结果支持该干预措施的可接受性和可行性,参与者的保留率(4 个月时为 85%,8 个月时为 78%)、Smart Walk 应用程序的使用情况以及干预满意度(即,100%完成干预的 PA 参与者[n=24]表示会向朋友推荐该干预措施)都证明了这一点。Smart Walk 参与者还报告称,他们的中等至剧烈 PA 增加了更多(4 个月时组间变化的差异[b]=43.3min/周;p=0.018;Cohen's d=0.69;8 个月时[b]=56.6min/周;p=0.046;d=0.63),并且在心肺适应性方面显示出具有临床意义的、尽管不具有统计学意义的(p 值>0.05)的改善,从基线到 4 个月的改善情况为心肺适应性(b=1.67mL/kg/min;d=0.40)、收缩压(b=-3.33mmHg;d=0.22)、舒张压(b=-4.28mmHg;d=0.37)和脉搏波速度(b=-0.46m/s;d=0.33)。8 个月时的心血管代谢结果也呈现出类似的趋势,但由于 COVID-19 限制,数据缺失率很高(45-53%)。总的来说,这些发现表明该干预措施在可接受性和可行性方面取得了良好的效果,同时也突出了未来研究中需要改进的关键领域。